<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">Pseudotumor cerebri</z:e>, also termed idiopathic intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo>, is defined by <z:hpo ids='HP_0002516'>increased intracranial pressure</z:hpo> in the setting of <z:mpath ids='MPATH_458'>normal</z:mpath> brain imaging and cerebrospinal fluid analysis </plain></SENT>
<SENT sid="1" pm="."><plain>It can often be associated with optic nerve head <z:hpo ids='HP_0000969'>edema</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Several medications have been associated with <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e>,(1) including the use of <z:chebi fb="0" ids="6504">lithium carbonate</z:chebi> in the adult population(3) as well as in adolescents.(4) Signs and symptoms of <z:hpo ids='HP_0002516'>increased intracranial pressure</z:hpo> typically resolve after cessation of <z:chebi fb="0" ids="6504">lithium carbonate</z:chebi> usage.(5) We report a case of the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e> associated with <z:chebi fb="32" ids="30145">lithium</z:chebi> treatment in a child who sustained long-term <z:hpo ids='HP_0000648'>optic atrophy</z:hpo> and <z:e sem="disease" ids="C0456909" disease_type="Disease or Syndrome" abbrv="">vision loss</z:e> and required <z:chebi fb="0" ids="27690">acetazolamide</z:chebi> treatment for approximately 1 year after cessation of <z:chebi fb="32" ids="30145">lithium</z:chebi> </plain></SENT>
</text></document>